These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6434462)

  • 21. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats.
    Abrams MJ; Juweid M; tenKate CI; Schwartz DA; Hauser MM; Gaul FE; Fuccello AJ; Rubin RH; Strauss HW; Fischman AJ
    J Nucl Med; 1990 Dec; 31(12):2022-8. PubMed ID: 2266401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carrier electrochemistry of pertechnetate: application to radiopharmaceutical labelling by controlled potential electrolysis at chemically inert electrodes.
    Russell CD
    Int J Appl Radiat Isot; 1977 Mar; 28(3):241-9. PubMed ID: 405335
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis, radiotechnetium labelling, and comparison of biologic behavior of longer-chain analogs of methylene diphosphonate.
    Wang TS; Hosain P; Spencer RP; Ahlquist K; Hosain F
    J Nucl Med; 1978 Oct; 19(10):1151-3. PubMed ID: 722328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new method for protein labeling with 99mTc.
    Blok D; Feitsma RI; Wasser MN; Nieuwenhuizen W; Pauwels EK
    Int J Rad Appl Instrum B; 1989; 16(1):11-6. PubMed ID: 2714995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation in vitro and in vivo of two labelling techniques of different 99mTc-dextrans for lymphoscintigraphy.
    Wingårdh K; Strand SE
    Eur J Nucl Med; 1989; 15(3):146-51. PubMed ID: 2469580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of 99mTc-labeled RBC.
    Colombetti L; Mahammadzadeh A; Ryo UY
    Radiobiol Radiother (Berl); 1976; 17(1):105-9. PubMed ID: 819959
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of 99mTc labelled Lipiodol: biodistribution following injection into the hepatic artery of the healthy pig.
    Garin E; Noiret N; Malbert CH; Lepareur N; Roucoux A; Dazord L; Caulet-Maugendre S; Turlin B; Moisan A; Lecloirec J; Herry JY; Boucher E; Raoul JL; Bourguet P
    Nucl Med Commun; 2004 Mar; 25(3):291-7. PubMed ID: 15094449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technetium-99m mercaptoalbumin as a potential substitute or technetium-99m labelled red blood cells.
    Verbeke KA; Vanbilloen HP; De Roo MJ; Verbruggen AM
    Eur J Nucl Med; 1993 Jun; 20(6):473-82. PubMed ID: 8339730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation, characterization and radiolabeling of a new amphiphilic derivative of DTPA.
    Aldenhoff YB; Van Kroonenburgh MJ; Koole LH
    Nucl Med Biol; 1996 Jul; 23(5):653-6. PubMed ID: 9044688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of reduction-mediated labelling of antibodies with technetium-99m.
    Zhang ZM; Ballinger JR; Sheldon K; Boxen I
    Int J Rad Appl Instrum B; 1992 Aug; 19(6):607-9. PubMed ID: 1522015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.
    Decristoforo C; Mather SJ
    Eur J Nucl Med; 1999 Aug; 26(8):869-76. PubMed ID: 10436200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of biological characteristics of EDTMP complexes with 99mTc, 111In and 153Sm in rats.
    Láznícek M; Láznícková A; Budský F; Prokop J; Kopicka K
    Appl Radiat Isot; 1994 Sep; 45(9):949-53. PubMed ID: 7951182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [99MTechnetium-fibrinogen labeling using electrolytic zircuronium release].
    Hebestreit HP; Pryss C
    Nucl Med (Stuttg); 1975 Jun; 14(2):172-84. PubMed ID: 1178516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative biodistribution studies of technetium-99 m radiolabeled amphiphilic nanoparticles using three different reducing agents during the labeling procedure.
    Geskovski N; Kuzmanovska S; Simonoska Crcarevska M; Calis S; Dimchevska S; Petrusevska M; Zdravkovski P; Goracinova K
    J Labelled Comp Radiopharm; 2013 Dec; 56(14):689-95. PubMed ID: 24339006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technetium-99m bis (aminoethanethiol) complexes with amine sidechains--potential brain perfusion imaging agents for SPECT.
    Efange SM; Kung HF; Billings J; Guo YZ; Blau M
    J Nucl Med; 1987 Jun; 28(6):1012-9. PubMed ID: 3108466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of chelator on the pharmacokinetics of 99mTc-labelled peptides.
    Decristoforo C; Mather SJ
    Q J Nucl Med; 2002 Sep; 46(3):195-205. PubMed ID: 12134136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Labeling and biodistribution studies of Tc-99m radiopharmaceuticals with (o-hydroxyphenyl)diphenylphosphine.
    Bolzati C; Uccelli L; Refosco F; Tisato F; Duatti A; Giganti M; Piffanelli A
    Nucl Med Biol; 1998 Jan; 25(1):71-6. PubMed ID: 9466365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A convenient method for the preparation of 99mTc(V)dimercaptosuccinic acid (99mTc(V)-DMSA).
    Westera G; Gadze A; Horst W
    Int J Appl Radiat Isot; 1985 Apr; 36(4):311-2. PubMed ID: 2991143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
    Stalteri MA; Mather SJ
    Eur J Nucl Med; 1996 Feb; 23(2):178-87. PubMed ID: 8925853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 99mTc(Sn) phosphocreatine: labeling characteristics and biological distribution.
    Castronovo FP; Deluca SA; Potsaid MS
    Int J Appl Radiat Isot; 1976 Feb; 27(2):93-6. PubMed ID: 1254348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.